<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="been observed against a wide range of viruses such as" exact="influenza" post="viruses, HIV, Enterovirus 71 (EV71), coxsackievirus A16 (CVA16), dengue"/>
 <result pre="HIV, Enterovirus 71 (EV71), coxsackievirus A16 (CVA16), dengue virus and" exact="chikungunya" post="virus [15, 16, 17, 18]. This review will elucidate"/>
 <result pre="virus The available therapeutic treatment for infection caused by the" exact="hepatitis" post="C virus have many adverse effects (Headache, fatigue, nausea,"/>
 <result pre="with anti-HCV drugs [33]. Hepatocarcinoma (HCC) is associated with chronic" exact="hepatitis" post="C virus (HCV) infection which involves increase in plasma"/>
 <result pre="polymerase components of virus to inhibit its replication, NS5B, a" exact="hepatitis" post="C virus polymerase is a novel target for newly"/>
 <result pre="plant Clausena excavate [43]. These compounds were found to inhibit" exact="hepatitis" post="B virus surface antigen (HBsAg) in HepA2 cells. Their"/>
 <result pre="[44]. From the aforementioned studies, we can deduce that in" exact="hepatitis" post="virus infection, coumarin has shown to target a wide"/>
 <result pre="brasiliense demonstrated strong inhibitory activity on HIV-1 replication by the" exact="suppression" post="of NF-kB activation in both acutely and chronically virus-infected"/>
 <result pre="Anti-viral therapy which are currently used for the treatment of" exact="influenza" post="viruses, have the limitations on vaccine design, efficacy and"/>
 <result pre="expression of many chemokine genes and gene for Nucleoprotein, an" exact="influenza" post="structural protein that is a constituent of vRNPs viral"/>
 <result pre="and cytokine-cytokine receptor interactions. Recently, the mechanism of action against" exact="influenza" post="viral infection of eleutheroside B1 has been assessed showing"/>
 <result pre="show promising antiviral against the H3N2 and H1N1 strains of" exact="influenza" post="in MDCK cell-based assays. Molecular docking studies has shown"/>
 <result pre="binding affinity between the coumarin derivative and target protein of" exact="influenza" post="virus using molecular docking [64]. Another research study has"/>
 <result pre="of a compound containing both coumarin and monoterpenoid derivative in" exact="influenza" post="was viral hemagglutinin HA which is involved in viral"/>
 <result pre="viral reproduction [60]. Due to the high mutation tendency of" exact="influenza" post="viral proteins [66], redox-sensitive pathways which are useful for"/>
 <result pre="different catechol and pyrogallol derivatives have shown antiviral activity against" exact="influenza" post="A H1N1 by modulating proteins involved in redox pathways"/>
 <result pre="Coumarin has the potential to significantly suppress the Dengue and" exact="chikungunya" post="viral infections in vitro. However, the need is to"/>
 <result pre="retention in nucleus mediated by Sirt1 deacetylase) this leads to" exact="suppression" post="of dengue virus replication by increasing the production of"/>
 <result pre="conjugates have been used to see their inhibitory role against" exact="chikungunya" post="viruses. Jih Ru Hwu et al., used the triply"/>
 <result pre="the triply conjugated uracil-coumarin-arenes compound to see structure-activity relationship against" exact="chikungunya" post="virus. In this research, coumarin central moiety was found"/>
 <result pre="size of conjugated moiety (benzouracil &amp;gt; thymine &amp;gt; uracil) and" exact="chikungunya" post="inhibitory action [3]. Same research group have synthesized thioguanosine-coumarin"/>
 <result pre="3RuJ.KapoorM.TsayS.LinC.ChuK.Benzouracil – coumarin – arene conjugates as inhibiting agents for" exact="chikungunya" post="virusAntivir. Res.201516 4BandarageU.K.ClarkM.P.PerolaE.GaoH.JacobsM.D.TsaiA.Novel 2-substituted 7-azaindole and 7-azaindazole analogues as"/>
 <result pre="of curcuminJ. Funct. Foods.402018692699 14KannanS.KolandaivelP.Antiviral potential of natural compounds against" exact="influenza" post="virus hemagglutininComput. Biol. Chem.2017 15WangC.Y.HuangS.C.ZhangY.LaiZ.R.KungS.H.ChangY.S.LinC.W.Antiviral ability of Kalanchoe gracilis"/>
 <result pre="and chronically infected cellsBioorg. Med. Chem. Lett23201360660923290051 29SandmannL.SchulteB.MannsM.P.MaasoumyB.Treatment of chronic" exact="hepatitis" post="C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating viral"/>
 <result pre="chronic hepatitis C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating" exact="viral hepatitis" post="C: efficacy, side effects, and complicationsGut5520061350135916905701 31LyT.PermanenteK.CaliforniaN.DermatolA.A.TineaM.S.GesD.D.ManagementG.R.CosmetC.DermatolI.ScH.TineaB.J.JsM.InfectE.LmD.BgR.KhR.ControlI.EpidemiolH.PcS.RcS.JournalB.Cutaneous side-effects of"/>
 <result pre="hepatitis C: efficacy, side effects and complicationsVis. Med.352019161170 30MannsM.P.WedemeyerH.CornbergM.Treating viral" exact="hepatitis" post="C: efficacy, side effects, and complicationsGut5520061350135916905701 31LyT.PermanenteK.CaliforniaN.DermatolA.A.TineaM.S.GesD.D.ManagementG.R.CosmetC.DermatolI.ScH.TineaB.J.JsM.InfectE.LmD.BgR.KhR.ControlI.EpidemiolH.PcS.RcS.JournalB.Cutaneous side-effects of"/>
 <result pre="U. K. experienceBr. J. Dermatol.201420142015 32HenryB.Drug pricing &amp;amp; challenges to" exact="hepatitis" post="C treatment accessJ. Heal. Biomed. Law.142018265283http://www.ncbi.nlm.nih.gov/pubmed/30258323%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6152913 33TsayS.LinS.HuangW.HsuM.HwangK.C.LinC.HorngJ.ChenI.HwuJ.R.ShiehF.LeyssenP.NeytsJ.Synthesis and Structure-activity"/>
 <result pre="Biomed. Law.142018265283http://www.ncbi.nlm.nih.gov/pubmed/30258323%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6152913 33TsayS.LinS.HuangW.HsuM.HwangK.C.LinC.HorngJ.ChenI.HwuJ.R.ShiehF.LeyssenP.NeytsJ.Synthesis and Structure-activity relationships of imidazole-coumarin conjugates against" exact="hepatitis" post="C virusMolecules2016 34RinoY.OhkawaS.ShimizuA.TamaiS.MiyakawaK.AokiH.ImadaT.ShindoK.OkamotoN.TotsukaS.Association between high serum alanine aminotransferase levels"/>
 <result pre="and more rapid development and higher rate of incidence of" exact="hepatocellular carcinoma" post="in patients with hepatitis C virus-associated cirrhosisCancer199958959510440686 35O. PaperClose"/>
 <result pre="higher rate of incidence of hepatocellular carcinoma in patients with" exact="hepatitis" post="C virus-associated cirrhosisCancer199958959510440686 35O. PaperClose association between high serum"/>
 <result pre="association between high serum ALT and more rapid recurrence of" exact="hepatocellular carcinoma" post="in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular"/>
 <result pre="recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver" exact="cirrhosis" post="and hepatocellular carcinomaIntervirology20002026081510773734 36OkamotoT.KajinoK.HinoO.Hepatoprotective drugs for the treatment of"/>
 <result pre="38HsuM.ShiehF.LinC.HwangK.C.Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit" exact="hepatitis" post="C virusSCEur. J. Med. Chem.2013 39NeytsJ.De ClercqE.SinghaR.ChangY.H.DasA.R.ChakrabortyS.K.Structure - activity"/>
 <result pre="40HwuJ.R.LinS.TsayS.De ClercqE.LeyssenP.NeytsJ.Coumarin - purine ribofuranoside conjugates as new agents against" exact="hepatitis" post="C virusJ. Med. Chem.20112114212621375337 41NicholsD.B.LeR.A.C.BasuA.ChudayeuM.De FP.MoraesD.TaleleT.T.PauloR.R.Kaushik-basuN.Evaluation of coumarin and"/>
 <result pre="inhibitorsChem. Biol. Drug Des.815201360761423311976 42PengH.ChenW.LeeJ.YangS.TzengC.LinY.YangS.Novel anilinocoumarin derivatives as agents against" exact="hepatitis" post="C virus by the induction of IFN-mediated antiviral responsesOrg."/>
 <result pre="scoparoneCurr. HIV Res.201648449027697031 59SpanakisN.PitirigaV.A review of neuraminidase inhibitor susceptibility in" exact="influenza" post="strainsExpert Rev. Anti-infect. Ther.20141325133625301229 60KhomenkoT.M.V ZarubaevV.OrshanskayaI.R.KadyrovaR.A.SannikovaV.A.V KorchaginaD.VolchoK.P.SalakhutdinovN.F.Bioorganic &amp;amp; medicinal"/>
 <result pre="roots of Glycyrrhiza uralensisBioorg. Med. Chem. Lett20201097197420064716 66EscuretV.FrobertE.Bouscambert-duchampM.SabatierM.GrogI.ValetteM.LinaB.MorfinF.FerrarisO.Detection of human" exact="influenza" post="A ( H1N1 ) and B strains with reduced"/>
 <result pre="carp virus infection in zebrafish Authors: SCVirus Res.2019 79MorensD.M.TaubenbergerJ.K.HarveyH.A.MemoliM.J.The 1918" exact="influenza" post="pandemic: lessons for 2009 and the futureCrit. Care Med.382010e10e2020048675"/>
 <result pre="mortality associated with the first 12 months of 2009 pandemic" exact="influenza" post="A H1N1 virus circulation: a modelling studyLancet Infect. Dis.129201268769522738893"/>
</results>
